oleanolic acid has been researched along with lamivudine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Ke, Z; Li, X; Lian, D; Pan, Y; Yuan, J | 1 |
| Huang, H; Li, Z; Liu, R; Min, Q; Zhu, Q; Zhu, Y | 1 |
3 other study(ies) available for oleanolic acid and lamivudine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Combination of saikosaponin c and telbivudine synergistically enhances the anti-HBV activity.
Topics: Antiviral Agents; DNA, Viral; Guanine; Hep G2 Cells; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Oleanolic Acid; Saponins; Telbivudine | 2020 |
Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors.
Topics: Antiviral Agents; DNA Replication; Dose-Response Relationship, Drug; Drug Design; Hepatitis B Surface Antigens; Hepatitis B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triterpenes | 2018 |